Direct evidence of oxidative injury produced by the Alzheimer's β-Amyloid peptide (1–40) in cultured hippocampal neurons

Marni E. Harris; Kenneth Hensley; D.Allan Butterfield; Robert A. Leedle; John M. Carney

doi:10.1016/0014-4886(95)90041-1

journal article Feb 01, 1995

Direct evidence of oxidative injury produced by the Alzheimer's β-Amyloid peptide (1–40) in cultured hippocampal neurons

Marni E. Harris Kenneth Hensley D.Allan Butterfield Robert A. Leedle John M. Carney

Experimental Neurology Vol. 131 No. 2 pp. 193-202 · Elsevier BV

View at Publisher Save 10.1016/0014-4886(95)90041-1

Topics

No keywords indexed for this article. Browse by subject →

References

53

[1]

Araujo "β-Amyloid stimulates glial cells in vitro to produce growth factors that accumulate in senile plaques in alzheimer's disease" Brain Res. (1992) 10.1016/0006-8993(92)90380-r

[2]

Arispe "Alzheimer disease amyloid β protein forms calcium channels in bilayer membranes: Blockade by tromethamine and aluminum" (1993)

[3]

Beal "Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?" Ann. Neurol. (1992) 10.1002/ana.410310202

[4]

Behl "Vitamin E protects nerve cells from amyloid β protein toxicity" Biochem. Biophys. Res. Commun. (1992) 10.1016/0006-291x(92)90837-b

[5]

Hydrogen peroxide mediates amyloid β protein toxicity

C Behl

Cell 1994 10.1016/0092-8674(94)90131-7

[6]

Bondy "Oxidative stress induced by glutamate receptor agonists" Brain Res. (1993) 10.1016/0006-8993(93)91405-h

[7]

Burdick "Assembly and aggregation properties of synthetic Alzheimer's A4/β amyloid peptide analogues" J. Biol. Chem. (1992) 10.1016/s0021-9258(18)48529-8

[8]

Busciglio "Methodological variables in the assessment of beta amyloid neurotoxicity" Neurobiol. Aging (1992) 10.1016/0197-4580(92)90065-6

[9]

Butterfield "β-Amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in an sequence-specific fashion: Implications to Alzheimer's disease" Biochem. Biophys. Res. Commun. (1994) 10.1006/bbrc.1994.1508

[10]

Del Rio-Hortega "Microglia" (1932)

[11]

Dyrks "Amyloidogenicity of βA4 and βA4-bearing amyloid protein precursor fragments by metal-catalyzed oxidation" J. Biol. Chem. (1992) 10.1016/s0021-9258(19)37174-1

[12]

Floyd "Use of salicylate with high performance liquid chromatography and electrochemical detection (LCED) as a sensitive measure of hydroxyl free radicals in adriamycin treated rats" Free Radical Biol. Med. (1986)

[13]

Frederickson "Astroglia in Alzheimer's disease" Neurobiol. Aging (1992) 10.1016/0197-4580(92)90036-w

[14]

Fucci "Inactivation of key metabolic enzymes by mixed-function oxidation reactions: Possible implications in protein turnover and ageing" (1983)

[15]

Ginsberg "Regional specificity of membrane instability in Alzheimer's disease brain" Brain Res. (1993) 10.1016/0006-8993(93)90050-w

[16]

Giordano "Similarities between β amyloid peptides 1–40 and 40-1: Effects on aggregation, toxicity in vitro, and injection in young and aged rats" Exper. Neurol. (1994) 10.1006/exnr.1994.1022

[17]

Goodman "Secreted forms of β-amyloid precursor protein protect hippocampal neurons against amyloid β-peptide toxicity and oxidative injury" Exper. Neural. (1994) 10.1006/exnr.1994.1107

[18]

Harris "Detection of Oxidation Products in Individual Neurons by Fluorescence Microscopy" Exper. Neurol. (1994) 10.1006/exnr.1994.1150

[19]

Hensley "A model for β-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: Relevance to Alzheimer disease" (1994)

[20]

Itagaki "Relationship of microglia and astrocytes to amyloid deposits in Alzheimer's disease" J. Neuroimmunol. (1989) 10.1016/0165-5728(89)90115-x

[21]

Jarrett "Seeding “one-dimensional crystallization” of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie?" Cell (1993) 10.1016/0092-8674(93)90635-4

[22]

Koh "β-Amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage" Brain Res. (1990) 10.1016/0006-8993(90)91355-k

[23]

Kontos "Oxygen radicals in CNS damage" Chem. Biol. Inter. (1989) 10.1016/0009-2797(89)90001-x

[24]

Leedle "Oxidation products in endothelial cells: A fluorescence microscopic method for visualizing carbonyls in situ" (1994)

[25]

Martins "Increased cerebral glucose-6-phosphate dehydrogenase activity in Alzheimer's disease may reflect oxidative stress" J. Neurochem. (1986) 10.1111/j.1471-4159.1986.tb00615.x

[26]

Mattson "Outgrowthregulating actions of glutamate in isolated hippocampal pyramidal neurons" J. Neurosci. (1988) 10.1523/jneurosci.08-06-02087.1988

[27]

Mattson "Isolated hippocampal neurons in cryopreserved long term culture: Development of neuroarchitecture and sensitivity to NMDA" Int. J. Dev. Neurosci. (1988) 10.1016/0736-5748(88)90050-0

[28]

Mattson "β-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity" J. Neurosci. (1992) 10.1523/jneurosci.12-02-00376.1992

[29]

Mattson "β-Amyloid precursor protein metabolites and loss of neuronal Ca2+ homeostasis in Alzheimer's disease" Trends Neurosci. (1993) 10.1016/0166-2236(93)90009-b

[30]

Mattson "Calcium-destabilizing and neurodegenerative effects of aggregated β-amyloid peptide are attenuated by basic FGF" Brain Res. (1993) 10.1016/0006-8993(93)90295-x

[31]

β-amyloid peptide in vitro toxicity: Lot-to-lot variability

Patrick C. May, Bruce D. Gitter, Diane C. Waters et al.

Neurobiology of Aging 1992 10.1016/0197-4580(92)90064-5

[32]

Oliver "Aβ role of mixed-function oxidation reactions in the accumulation of altered enzyme forms during aging" J. Am. Geriair. Soc. (1987) 10.1111/j.1532-5415.1987.tb02297.x

[33]

Orrenius "Role of Ca2+ in toxic cell killing" Trends Pharmacol. Sci. (1989) 10.1016/0165-6147(89)90029-1

[34]

Pellerin "Release of arachidonic acid by NMDA-receptor activation in the rat hippocampus" Neurochem. Res. (1991) 10.1007/bf00965841

[35]

Pike "Aggregation-related toxicity of synthetic β-amyloid protein in hippocampal cultures" Eur. J. Pharmacol. (1991) 10.1016/0922-4106(91)90014-9

[36]

Pike "In vitro aging of B-amyloid protein causes peptide aggregation and neurotoxicity" Brain Res. (1991) 10.1016/0006-8993(91)91553-d

[37]

Pike "β-Amyloid induces neuritic dystrophy in vitro: similarities with Alzheimer pathology" Neuroreport (1992) 10.1097/00001756-199209000-00012

[38]

Pike "Neurodegeneration induced by β-amyloid peptides in vitro: the role of peptide assemble state" J. Neurosci. (1993) 10.1523/jneurosci.13-04-01676.1993

[39]

Potter "The involvement of astrocytes and an acute phase response in the amyloid deposition of Alzheimer's disease" Prog. Brain Res. (1992) 10.1016/s0079-6123(08)61772-0

[40]

Probst "Aβ special type of senile plaque, possibly an initial stage" Acta Neuropothol. (1988) 10.1007/bf00692843

[41]

Rowe "Glutamine Synthetase (Sheep Brain)" Methods Enzymol. (1970) 10.1016/0076-6879(71)17304-1

[42]

Selkoe "Biochemistry of altered brain proteins in Alzheimer's disease" Annu. Rev. Neurosci. (1989) 10.1146/annurev.ne.12.030189.002335

[43]

Selkoe "The molecular pathology of Alzheimer's disease" Neuron (1991) 10.1016/0896-6273(91)90052-2

[44]

Simmons "Secondary structure of amyloid β peptide correlates with neurotoxic activity in vitro" Mol. Pharmacol. (1994)

[45]

Simmons "Amyloid β peptides act directly on single neurons" Neurosci. Lett. (1993) 10.1016/0304-3940(93)90519-q

[46]

Smith "Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease" (1991)

[47]

Metal ion-catalyzed oxidation of proteins: Biochemical mechanism and biological consequences

Earl R. Stadtman

Free Radical Biology and Medicine 1990 10.1016/0891-5849(90)90006-5

[48]

Subbarao "Autopsy samples of Alzheimer's cortex show increased peroxidation in vitro" J. Neurochem. (1990) 10.1111/j.1471-4159.1990.tb08858.x

[49]

Tomski "Kinetics of aggregation of synthetic β-Amyloid peptide" Arch. Biochem. Biophys. (1992) 10.1016/0003-9861(92)90735-f

[50]

Volicer "Involvement of free radicals in dementia of the Alzheimer type: A hypothesis" Neurobiol. Aging (1990) 10.1016/0197-4580(90)90119-k

Showing 50 of 53 references

Cited By

273

Neuroprotective Effects of Chronic Resveratrol Treatment and Exercise Training in the 3xTg-AD Mouse Model of Alzheimer’s Disease

Tom L. Broderick, Suhail Rasool · 2020

International Journal of Molecular...

Metrics

273

Citations

53

References

Details

Published: Feb 01, 1995
Vol/Issue: 131(2)
Pages: 193-202
License: View

Authors

Department of Pathology and Department of Neurosciences, University of Toledo Health Sciences Center, Toledo, OH, USA

Cite This Article

Marni E. Harris, Kenneth Hensley, D.Allan Butterfield, et al. (1995). Direct evidence of oxidative injury produced by the Alzheimer's β-Amyloid peptide (1–40) in cultured hippocampal neurons. Experimental Neurology, 131(2), 193-202. https://doi.org/10.1016/0014-4886(95)90041-1

Direct evidence of oxidative injury produced by the Alzheimer's β-Amyloid peptide (1–40) in cultured hippocampal neurons

You May Also Like